EraCal Therapeutics
PrivateLast Round
Seed
Oct 16, 2019
Total Funding Raised
$1.14M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
EraCal Therapeutics operates in Healthcare & Life Sciences and is based in Schlieren. Its latest recorded funding round was a Seed round in October 2019.
EraCal Therapeutics is a biotechnology company that develops drugs to treat metabolic syndrome and obesity using its in-vivo screening platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EraCal Therapeutics Comparables
Compare EraCal Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eolo Pharma | 76% | |
| Resalis Therapeutics | 76% | |
| Kallyope | 74% |
For institutional investors. Book with your work email.
EraCal Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 16, 2019 | ||||
| Grant | Feb 1, 2019 |
For institutional investors. Book with your work email.
EraCal Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Zurich | Seed |
| Redalpine | Seed |
| Venture Kick | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 132% MoM.
- Jul 3, 2025
Monthly visitors increased 151% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
EraCal Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EraCal Therapeutics's valuation, stock price, and market status.
Is EraCal Therapeutics a public or private company?
EraCal Therapeutics is a private company.
What is the current stock price of EraCal Therapeutics?
EraCal Therapeutics is a private company, so its shares have no public market price. Caplight tracks EraCal Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EraCal Therapeutics worth (valuation)?
Valuation information for EraCal Therapeutics is not publicly available.
Can I buy EraCal Therapeutics stock?
EraCal Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EraCal Therapeutics's last funding round?
EraCal Therapeutics's most recent funding round was Seed on October 16, 2019.
Who are the main investors in EraCal Therapeutics?
Key investors in EraCal Therapeutics include Redalpine.
Will EraCal Therapeutics IPO soon?
No public IPO plans have been announced for EraCal Therapeutics.
How can I track EraCal Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in EraCal Therapeutics's shares on secondary markets.